GlassScriptPhysician profile
Tzvi Nussbaum
NPI 1205938255
$15,924.18
in general payments reported to CMS, 2019-2025
19 companies · $649 in 2025
The $649 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,783 · 2020: $1,902 · 2021: $1,972 · 2022: $3,202 · 2023: $1,740 · 2024: $1,677 · 2025: $649.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,067.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,066.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,475.27 | 2021-2025 | Endurant Iis, Valiant Captivia, Ligasure |
| Medtronic Vascular, INC. | $2,455.70 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $1,630.93 | 2019-2020 | |
| Philips North America LLC | $968.44 | 2019-2024 | (Br5) Peripheral Ivus |
| W. L. Gore & Associates, INC. | $902.80 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Acuseal Vascular Graft, Gore Intering Vascular Graft |
| Silk Road Medical, INC. | $819.20 | 2019 | |
| Cook Medical LLC | $741.61 | 2020-2024 | Zilver Ptx, Rosen |
| Shockwave Medical, INC | $714.06 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $707.90 | 2021-2025 | General - Thrombectomy, Ekosonic, Eluvia |
| Penumbra, INC. | $412.81 | 2019-2024 | Indigo System |
| Kerecis Limited | $246.73 | 2021-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Biom'Up France Sas | $238.91 | 2020-2021 | |
| Artivion, INC. | $197.27 | 2021 | |
| Getinge USA Sales, LLC | $186.58 | 2022 | |
| Abbott Laboratories | $125.84 | 2024 | Diamondback Peripheral |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elutia, INC. | $48.47 | 2019 | |
| Humacyte Global, INC. | $27.58 | 2025 | Symvess |
| Lemaitre Vascular, INC. | $24.08 | 2025 | Hydro Lemaitre Valvulotome |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tzvi Nussbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.